Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
$ 59.1
0.323 %
$ 10.7 B
Market Cap
-25.92
P/E
Price Target
Average
7.45%
Revenue Forecast
Estimate
7.33%
EBIT
Estimate
25.37%
Net Income
Estimate
34.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Catalent, Inc.
Wall Street analysts predict an average 1-year price target for CTLT of $63.5 , with forecasts ranging from a low of $63.5 to a high of $63.5 .
CTLT Lowest Price Target
Wall Street Target
63.5 USD
7.45%
CTLT Average Price Target
Wall Street Target
63.5 USD
7.45%
CTLT Highest Price Target
Wall Street Target
63.5 USD
7.45%
REVENUE FORECAST
Revenue Forecast Chart CTLT
EBIT FORECAST
EBIT Forecast Chart CTLT
NET INCOME FORECAST
Net Income Chart CTLT